vitiligo treatment

Daily Hot Takes from SOCU 2026: Day 3 & Conference Wrap-Up
A Historic Conclusion to the 17th Annual Skin of Color Update! The 17th Annual Skin of Color Update (SOCU 2026) came to an inspiring conclusion yesterday in New York City, completing three days of unprecedented scholarship, clinical innovation, and community building. Co-Chairs Andrew F. Alexis, MD, MPH, FAAD, and Eliot F. Battle, MD, along with Program Development Advisor Heather Woolery-Lloyd, …
Going In-Depth on Pigmentary Disorders: Dr. Pearl Grimes on Why PDE is a Must-Attend Conference
Pigmentary Disorders Exchange (PDE) SymposiumFor dermatology clinicians, staying at the forefront of therapeutic advances is essential, especially when it comes to conditions that carry profound psychosocial burdens for patients. Few areas in dermatology are evolving as rapidly, or demand as much clinical nuance, as the study and treatment of pigmentary disorders. To dive deeper into these complexities, our friends at Practical Dermatology …
Pigmentary Disorders Exchange (PDE) Symposium
JAK Inhibitors in Dermatology Patients With Skin of Color
Dr. Brett King discussing the clinical use and safety of JAK inhibitors for treating inflammatory skin conditions in patients with skin of color.Dermatologists must become comfortable prescribing JAK inhibitors in patients with skin of color in order to provide high-quality dermatologic care. That’s according to Dr. Brett King, a dermatologist in Fairfield, Conn., who was the first dermatologist to show that JAK inhibitors as a medicine class were effective in treating a spectrum of dermatologic conditions, including alopecia areata and …
Dr. Brett King discussing the clinical use and safety of JAK inhibitors for treating inflammatory skin conditions in patients with skin of color.
Advancing Vitiligo Treatment: Insights on Current and Emerging Therapies by Dr. Rebecca Vasquez
vitiligo patientAt the Skin of Color Update 2024, we had the honor to learn from Dr. Rebecca Vasquez, Associate Professor at UT Southwestern Medical Center, regarding the evolving field of vitiligo management. Vitiligo affects between 0.5% to 2% of the global population, with no racial or gender preference, yet it carries a significant psychological burden for affected individuals.1 Dr. Vasquez emphasized that vi …
vitiligo patient
Chemical Peels, PRP, and Microneedling Best Practices
microneedlingAt the 2024 Pigmentary Disorders Exchange Symposium in Chicago, Dr. Pearl Grimes, a leading international authority on vitiligo and pigmentation disorders, delivered an insightful lecture on the best practice for using chemical peels, microneedling and PRP  in dermatology. Dr. Grimes' presentation delved into the nuances of various peeling agents, their indications, and key considerations for the …
microneedling